cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biolife Solutions Inc
14 own
17 watching
Current Price
$24.43
$-1.59
(-6.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,043.31M
52-Week High
52-Week High
29.92
52-Week Low
52-Week Low
10.4
Average Volume
Average Volume
0.27M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
310.1434
iconMarket Capitalization1,043.31M
icon52-Week High29.92
icon52-Week Low10.4
iconAverage Volume0.27M
iconDividend Yield--
iconP/E Ratio310.1434
What does the Biolife Solutions Inc do?
BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. The company's products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. It offers HypoThermosol FRS, a hypothermic storage and shipping media product to reduce post-preservation necrosis and apoptosis; CryoStor cryopreservation freeze media products, which are designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing; and BloodStor products comprising BloodStor 55-5 and BloodStor 100 for cryopreservation of cells isolated from umbilical cord blood, peripheral blood, and bone marrow. The company also provides cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants; and PrepaStor, a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. In addition, it offers custom product formulation and custom packaging services; precision thermal packaging products and cloud-hosted Web applications; and contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The company markets its products to the bio banking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. BioLife Solutions, Inc. was founded in 1987 and is based in Bothell, Washington.
Read More
How much money does Biolife Solutions Inc make?
News & Events about Biolife Solutions Inc.
Globe Newswire
13days ago
LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- iVexSol Inc., a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO), announced $23.8 million in Series A-3 funding. New investors Bristol Myers Squibb (NYSE: BMY), Charles River Laboratories (NYSE: ...
PR Newswire
1month ago
BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023 BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023 PR Newswire BOTHELL, Wash., Dec. 19, 2022 Announcement Precedes Meetings to be...
PR Newswire
2 months ago
BioLife Solutions Expands Intellectual Property Estate BioLife Solutions Expands Intellectual Property Estate PR Newswire BOTHELL, Wash., Nov. 21, 2022 7 New Granted Patents; 43 Submitted Patent Applications Global Portfolio Now Totals 148 Issued and 114 Pending Patents BOTHELL, Wash., Nov. 21...
PR Newswire
5 months ago
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors PR Newswire BOTHELL, Wash., Aug. 25, 2022 Industry veteran brings extensive technical operations scale-up...
Ticker Report
6 months ago
New York State Common Retirement Fund grew its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS Get Rating) by 6.5% during the first quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The institutional investor owned 191,555 ...
Frequently Asked Questions
Frequently Asked Questions
What is Biolife Solutions Inc share price today?
plus_minus_icon
Can Indians buy Biolife Solutions Inc shares?
plus_minus_icon
How can I buy Biolife Solutions Inc shares from India?
plus_minus_icon
Can Fractional shares of Biolife Solutions Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biolife Solutions Inc stocks?
plus_minus_icon
What is today’s traded volume of Biolife Solutions Inc?
plus_minus_icon
What is today’s market capitalisation of Biolife Solutions Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biolife Solutions Inc?
plus_minus_icon
What percentage is Biolife Solutions Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biolife Solutions Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$24.43
$-1.59
(-6.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$10.38
$-0.09 (-0.86 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$9.96
$0.40 (4.18 %)
Cymabay Therapeutics Inc
Cymabay Therapeutics Inc
$8.50
$0.15 (1.80 %)
CareDx, Inc.
CareDx, Inc.
$16.56
$0.30 (1.85 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$10.38
$-0.09 (-0.86 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$9.96
$0.40 (4.18 %)
Cymabay Therapeutics Inc
Cymabay Therapeutics Inc
$8.50
$0.15 (1.80 %)
CareDx, Inc.
CareDx, Inc.
$16.56
$0.30 (1.85 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00